 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Passage BIO Inc. (PASG)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-03-03 Purchase | 2020-03-03 6:35 pm | Passage BIO Inc. | PASG | Cale Edgar B. GC and Corporate Secretary | 2,000 | $18 | $36,000 | 2,000 (Direct) | View |
| 2020-03-03 Purchase | 2020-03-03 6:37 pm | Passage BIO Inc. | PASG | Countouriotis Athena Director | 8,900 | $18 | $160,200 | 8,900 (Direct) | View |
| 2020-03-03 Purchase | 2020-03-03 6:38 pm | Passage BIO Inc. | PASG | Fotopoulos Alexandros CTO | 5,500 | $18 | $99,000 | 5,500 (Direct) | View |
| 2020-03-03 Purchase | 2020-03-03 6:40 pm | Passage BIO Inc. | PASG | Goldsmith Bruce A CEO | 1,100 | $18 | $19,800 | 1,100 (Direct) | View |
| 2020-03-03 Purchase | 2020-03-03 6:41 pm | Passage BIO Inc. | PASG | Islam Saqib Director | 5,000 | $18 | $90,000 | 5,000 (Direct) | View |
| 2020-03-03 Purchase | 2020-03-03 6:43 pm | Passage BIO Inc. | PASG | Kapadia Sandip Director | 5,000 | $18 | $90,000 | 5,000 (Direct) | View |
| 2020-03-03 Purchase | 2020-03-03 6:44 pm | Passage BIO Inc. | PASG | Morris Richard Steven CFO | 400 | $18 | $7,200 | 400 (Direct) | View |
| 2020-03-03 Purchase | 2020-03-03 6:46 pm | Passage BIO Inc. | PASG | Quigley Jill M. COO | 2,500 | $18 | $45,000 | 1,000 (Indirect Direct) | View |
| 2020-03-03 Purchase | 2020-03-03 6:48 pm | Passage BIO Inc. | PASG | Ratcliffe Liam Director | 2,800 | $18 | $50,400 | 2,800 (Direct) | View |
| 2020-03-03 Purchase | 2020-03-03 6:51 pm | Passage BIO Inc. | PASG | Yamada Tadataka Director | 6,500 | $18 | $117,000 | 656,149 (Direct) | View |
| 2020-03-03 Purchase | 2020-03-03 6:54 pm | Passage BIO Inc. | PASG | Heron Patrick J Director 10% Owner | 550,000 | $18 | $9,900,000 | 5,009,219 (Indirect) | View |
| 2020-03-03 Purchase | 2020-03-03 6:57 pm | Passage BIO Inc. | PASG | Woiwode Thomas Director 10% Owner | 225,000 | $18 | $4,050,000 | 933,352 (Indirect) | View |
| 2020-03-03 Purchase | 2020-03-03 6:59 pm | Passage BIO Inc. | PASG | Frazier Life Sciences IX L.P. FHMLS IX L.P. FHMLS IX L.L.C. Topper James N 10% Owner | 550,000 | $18 | $9,900,000 | 5,009,219 (Direct) | View |
| 2020-03-03 Purchase | 2020-03-03 7:03 pm | Passage BIO Inc. | PASG | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Woiwode Thomas 10% Owner | 225,000 | $18 | $4,050,000 | 933,352 (Indirect Direct) | View |
| 2020-02-28 Purchase | 2020-03-03 7:07 pm | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 373,300 | $18 | $6,719,400 | 373,300 (Indirect) | View |
| 2020-03-03 Purchase(A) | 2020-03-13 5:20 pm | Passage BIO Inc. | PASG | Ratcliffe Liam Director | 552,800 | $18 | $9,950,400 | 2,800 (Indirect Direct) | View |
| 2020-03-24 Purchase | 2020-03-25 8:26 pm | Passage BIO Inc. | PASG | Countouriotis Athena Director | 10,000 | $14.98 | $149,750 | 18,900 (Direct) | View |
| 2021-01-14 Sale | 2021-01-15 8:29 pm | Passage BIO Inc. | PASG | Quigley Jill M. COO | 16,298 | $30.1 | $490,570 | 296,584 (Indirect Direct) | View |
| 2021-01-20 Sale | 2021-01-22 5:54 pm | Passage BIO Inc. | PASG | Quigley Jill M. COO | 1,300 | $30.01 | $39,011 | 295,284 (Indirect Direct) | View |
| 2021-03-15 Sale | 2021-03-17 9:12 pm | Passage BIO Inc. | PASG | Romano Gary Chief Medical Officer | 10,000 | $21.1 | $211,013 | 0 (Direct) | View |
| 2021-05-21 Purchase | 2021-05-21 6:05 pm | Passage BIO Inc. | PASG | Goldsmith Bruce A CEO | 2,000 | $13.11 | $26,230 | 5,983 (Direct) | View |
| 2021-05-21 Purchase | 2021-05-21 6:09 pm | Passage BIO Inc. | PASG | Morris Richard Steven CFO | 2,171 | $13.82 | $30,000 | 5,454 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-02-27 Option Award | 2020-03-02 6:05 pm | N/A 2030-02-27 | Passage BIO Inc. | PASG | Countouriotis Athena Director | 33,836 | $0 | 33,836 (Direct) | View |
| 2020-03-03 Conversion | 2020-03-03 6:54 pm | N/A N/A | Passage BIO Inc. | PASG | Heron Patrick J Director 10% Owner | 2,977,242 | $0 | 2,977,242 (Indirect) | View |
| 2020-03-03 Conversion | 2020-03-03 6:54 pm | N/A N/A | Passage BIO Inc. | PASG | Heron Patrick J Director 10% Owner | 1,049,175 | $0 | 4,026,417 (Indirect) | View |
| 2020-03-03 Conversion | 2020-03-03 6:54 pm | N/A N/A | Passage BIO Inc. | PASG | Heron Patrick J Director 10% Owner | 432,802 | $0 | 4,459,219 (Indirect) | View |
| 2020-03-03 Conversion | 2020-03-03 6:54 pm | N/A N/A | Passage BIO Inc. | PASG | Heron Patrick J Director 10% Owner | 2,977,242 | $0 | 0 (Indirect) | View |
| 2020-03-03 Conversion | 2020-03-03 6:54 pm | N/A N/A | Passage BIO Inc. | PASG | Heron Patrick J Director 10% Owner | 1,049,175 | $0 | 0 (Indirect) | View |
| 2020-03-03 Conversion | 2020-03-03 6:54 pm | N/A N/A | Passage BIO Inc. | PASG | Heron Patrick J Director 10% Owner | 432,802 | $0 | 0 (Indirect) | View |
| 2020-03-03 Conversion | 2020-03-03 6:57 pm | N/A N/A | Passage BIO Inc. | PASG | Woiwode Thomas Director 10% Owner | 2,977,242 | $0 | 2,977,242 (Indirect) | View |
| 2020-03-03 Conversion | 2020-03-03 6:57 pm | N/A N/A | Passage BIO Inc. | PASG | Woiwode Thomas Director 10% Owner | 1,049,175 | $0 | 4,026,417 (Indirect) | View |
| 2020-03-03 Conversion | 2020-03-03 6:57 pm | N/A N/A | Passage BIO Inc. | PASG | Woiwode Thomas Director 10% Owner | 708,352 | $0 | 708,352 (Indirect) | View |
| 2020-03-03 Conversion | 2020-03-03 6:57 pm | N/A N/A | Passage BIO Inc. | PASG | Woiwode Thomas Director 10% Owner | 2,977,242 | $0 | 0 (Indirect) | View |
| 2020-03-03 Conversion | 2020-03-03 6:57 pm | N/A N/A | Passage BIO Inc. | PASG | Woiwode Thomas Director 10% Owner | 1,049,175 | $0 | 0 (Indirect) | View |
| 2020-03-03 Conversion | 2020-03-03 6:57 pm | N/A N/A | Passage BIO Inc. | PASG | Woiwode Thomas Director 10% Owner | 708,352 | $0 | 0 (Indirect) | View |
| 2020-03-03 Conversion | 2020-03-03 6:59 pm | N/A N/A | Passage BIO Inc. | PASG | Frazier Life Sciences IX L.P. FHMLS IX L.P. FHMLS IX L.L.C. Topper James N 10% Owner | 2,977,242 | $0 | 2,977,242 (Direct) | View |
| 2020-03-03 Conversion | 2020-03-03 6:59 pm | N/A N/A | Passage BIO Inc. | PASG | Frazier Life Sciences IX L.P. FHMLS IX L.P. FHMLS IX L.L.C. Topper James N 10% Owner | 1,049,175 | $0 | 4,026,417 (Direct) | View |
| 2020-03-03 Conversion | 2020-03-03 6:59 pm | N/A N/A | Passage BIO Inc. | PASG | Frazier Life Sciences IX L.P. FHMLS IX L.P. FHMLS IX L.L.C. Topper James N 10% Owner | 432,802 | $0 | 4,459,219 (Direct) | View |
| 2020-03-03 Conversion | 2020-03-03 6:59 pm | N/A N/A | Passage BIO Inc. | PASG | Frazier Life Sciences IX L.P. FHMLS IX L.P. FHMLS IX L.L.C. Topper James N 10% Owner | 2,977,242 | $0 | 0 (Direct) | View |
| 2020-03-03 Conversion | 2020-03-03 6:59 pm | N/A N/A | Passage BIO Inc. | PASG | Frazier Life Sciences IX L.P. FHMLS IX L.P. FHMLS IX L.L.C. Topper James N 10% Owner | 1,049,175 | $0 | 0 (Direct) | View |
| 2020-03-03 Conversion | 2020-03-03 6:59 pm | N/A N/A | Passage BIO Inc. | PASG | Frazier Life Sciences IX L.P. FHMLS IX L.P. FHMLS IX L.L.C. Topper James N 10% Owner | 432,802 | $0 | 0 (Direct) | View |
| 2020-03-03 Conversion | 2020-03-03 7:03 pm | N/A N/A | Passage BIO Inc. | PASG | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Woiwode Thomas 10% Owner | 2,977,242 | $0 | 2,977,242 (Direct) | View |
| 2020-03-03 Conversion | 2020-03-03 7:03 pm | N/A N/A | Passage BIO Inc. | PASG | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Woiwode Thomas 10% Owner | 1,049,175 | $0 | 4,026,417 (Direct) | View |
| 2020-03-03 Conversion | 2020-03-03 7:03 pm | N/A N/A | Passage BIO Inc. | PASG | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Woiwode Thomas 10% Owner | 708,352 | $0 | 708,352 (Indirect) | View |
| 2020-03-03 Conversion | 2020-03-03 7:03 pm | N/A N/A | Passage BIO Inc. | PASG | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Woiwode Thomas 10% Owner | 2,977,242 | $0 | 0 (Direct) | View |
| 2020-03-03 Conversion | 2020-03-03 7:03 pm | N/A N/A | Passage BIO Inc. | PASG | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Woiwode Thomas 10% Owner | 1,049,175 | $0 | 0 (Direct) | View |
| 2020-03-03 Conversion | 2020-03-03 7:03 pm | N/A N/A | Passage BIO Inc. | PASG | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Woiwode Thomas 10% Owner | 708,352 | $0 | 0 (Indirect) | View |
| 2020-02-28 Conversion | 2020-03-03 7:07 pm | N/A N/A | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 3,721,552 | $0 | 4,094,852 (Indirect) | View |
| 2020-02-28 Conversion | 2020-03-03 7:07 pm | N/A N/A | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 1,311,469 | $0 | 5,406,321 (Indirect) | View |
| 2020-02-28 Conversion | 2020-03-03 7:07 pm | N/A N/A | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 541,002 | $0 | 5,947,323 (Indirect) | View |
| 2020-02-28 Conversion | 2020-03-03 7:07 pm | N/A N/A | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 3,721,552 | $0 | 0 (Indirect) | View |
| 2020-02-28 Conversion | 2020-03-03 7:07 pm | N/A N/A | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 1,311,469 | $0 | 0 (Indirect) | View |
| 2020-02-28 Conversion | 2020-03-03 7:07 pm | N/A N/A | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 541,002 | $0 | 0 (Indirect) | View |
| 2020-03-03 Conversion | 2020-03-13 5:20 pm | N/A N/A | Passage BIO Inc. | PASG | Ratcliffe Liam Director | 2,066,630 | $0 | 2,066,630 (Indirect) | View |
| 2020-03-03 Conversion | 2020-03-13 5:20 pm | N/A N/A | Passage BIO Inc. | PASG | Ratcliffe Liam Director | 2,066,630 | $0 | 0 (Indirect) | View |
| 2021-02-16 Option Award | 2021-02-18 7:24 pm | N/A 2031-02-15 | Passage BIO Inc. | PASG | Fotopoulos Alexandros CTO | 105,000 | $0 | 105,000 (Direct) | View |
| 2021-02-16 Option Award | 2021-02-18 7:26 pm | N/A 2031-02-15 | Passage BIO Inc. | PASG | Goldsmith Bruce A CEO | 262,000 | $0 | 262,000 (Direct) | View |
| 2021-02-16 Option Award | 2021-02-18 7:27 pm | N/A 2031-02-15 | Passage BIO Inc. | PASG | Cale Edgar B. GC and Corporate Secretary | 170,997 | $0 | 170,997 (Direct) | View |
| 2021-02-16 Option Award | 2021-02-18 7:28 pm | N/A 2031-02-15 | Passage BIO Inc. | PASG | Romano Gary Chief Medical Officer | 105,000 | $0 | 105,000 (Direct) | View |
| 2021-02-16 Option Award | 2021-02-18 7:33 pm | N/A 2031-02-15 | Passage BIO Inc. | PASG | Morris Richard Steven CFO | 50,000 | $0 | 50,000 (Direct) | View |
| 2021-02-16 Option Award | 2021-02-18 7:34 pm | N/A 2031-02-15 | Passage BIO Inc. | PASG | Quigley Jill M. COO | 105,000 | $0 | 105,000 (Direct) | View |
| 2021-02-18 Option Award | 2021-02-22 5:45 pm | N/A 2031-02-17 | Passage BIO Inc. | PASG | GOWEN MAXINE Director | 33,836 | $0 | 33,836 (Direct) | View |
| 2021-03-15 Exercise | 2021-03-17 9:12 pm | N/A N/A | Passage BIO Inc. | PASG | Romano Gary Chief Medical Officer | 10,000 | $8.07 | 10,000 (Direct) | View |
| 2021-03-15 Exercise | 2021-03-17 9:12 pm | N/A 2029-10-23 | Passage BIO Inc. | PASG | Romano Gary Chief Medical Officer | 10,000 | $0 | 300,821 (Direct) | View |
| 2021-03-22 Option Award | 2021-03-29 7:01 pm | N/A 2031-03-22 | Passage BIO Inc. | PASG | Salinas Eliseo Oreste Chief Res. & Develop Officer | 275,000 | $0 | 275,000 (Direct) | View |
| 2021-03-22 Option Award | 2021-03-29 7:01 pm | N/A N/A | Passage BIO Inc. | PASG | Salinas Eliseo Oreste Chief Res. & Develop Officer | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-03-22 Option Award | 2021-03-29 7:01 pm | N/A N/A | Passage BIO Inc. | PASG | Salinas Eliseo Oreste Chief Res. & Develop Officer | 60,000 | $0 | 60,000 (Direct) | View |
| 2021-05-17 Option Award | 2021-05-19 7:04 pm | N/A N/A | Passage BIO Inc. | PASG | Fotopoulos Alexandros CTO | 50,000 | $0 | 50,000 (Direct) | View |
| 2021-05-27 Option Award | 2021-05-28 5:50 pm | N/A 2031-05-26 | Passage BIO Inc. | PASG | Countouriotis Athena Director | 16,918 | $0 | 16,918 (Direct) | View |
| 2021-05-27 Option Award | 2021-05-28 5:56 pm | N/A 2031-05-26 | Passage BIO Inc. | PASG | Porter Derrell Director | 33,836 | $0 | 33,836 (Direct) | View |
| 2021-05-27 Option Award | 2021-05-28 5:58 pm | N/A 2031-05-26 | Passage BIO Inc. | PASG | Ratcliffe Liam Director | 16,918 | $0 | 16,918 (Direct) | View |
| 2021-05-27 Option Award | 2021-05-28 6:01 pm | N/A 2031-05-26 | Passage BIO Inc. | PASG | Kapadia Sandip Director | 16,918 | $0 | 16,918 (Direct) | View |
| 2021-05-27 Option Award | 2021-05-28 6:02 pm | N/A 2031-05-26 | Passage BIO Inc. | PASG | Islam Saqib Director | 16,918 | $0 | 16,918 (Direct) | View |
| 2021-05-27 Option Award | 2021-05-28 6:04 pm | N/A 2031-05-26 | Passage BIO Inc. | PASG | Yamada Tadataka Director | 16,918 | $0 | 16,918 (Direct) | View |
| 2021-05-27 Option Award | 2021-05-28 6:06 pm | N/A 2031-05-26 | Passage BIO Inc. | PASG | Woiwode Thomas Director 10% Owner | 16,918 | $0 | 16,918 (Direct) | View |
| 2021-05-27 Option Award | 2021-06-01 1:51 pm | N/A 2031-05-26 | Passage BIO Inc. | PASG | GOWEN MAXINE Director | 4,542 | $0 | 4,542 (Direct) | View |